Keyword: Sunovion Pharmaceuticals
Sunovion is looking for a hero. Epilepsy heroes, that is.
AbbVie’s Humira finished the last month of 2016 in much the same way it did most of the year—as the No. 1 national TV ad spender among pharma brands.
Sunovion’s COPD treatment passed muster in Phase III for both safety and efficacy, marking a success for its quick-acting nebulizer delivery system.